Respiratory Drugs Market is forecast to rise from a value of $28.1 Respiratory Drugs Market 2022

Respiratory Drugs Market is forecast to rise
from a value of $28.1 billion in 2015 to $46.6
billion in 2022: Radiant Insights, Inc
“The respiratory disorders market is forecast to rise
from a value of $28.1 billion in 2015 to $46.6 billion
in 2022, at a CAGR of 7.5%.”
Summary
The respiratory therapy area consists of indications that affect the respiratory system in different
ways, such as the scarring of lung tissue, and excessive production of mucus in the airways,
thereby decreasing lung function. Some of the key indications in this therapy area include asthma,
chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and idiopathic pulmonary
fibrosis (IPF). The causes of respiratory disorders vary significantly across each indication, and
include factors such as environment, occupation, genetic predisposition and aging.
The treatment landscape for respiratory disorders has traditionally been dominated by small
molecule therapies that aim to treat the disease symptoms, rather than the cause. This means that
treatment options can be diverse in terms of their targets and mechanisms of action. This is most
notable in CF, where patients may be prescribed a combination of drugs from several treatment
categories, including mucolytic agents, bronchodilators and antibiotics.
Click Here For Complete Report @ http://www.radiantinsights.com/research/global-
respiratory-drugs-market-to-2022
Follow Us: